메뉴 건너뛰기




Volumn 6, Issue 3, 2006, Pages 187-208

Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: Topical therapeutic strategies targeting COX-2 expression and activity

Author keywords

Cancer; Cyclooxygenase 2; Signaling pathways; Therapeutic strategy

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CETUXIMAB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EPIGALLOCATECHIN GALLATE; ERLOTINIB; GEFITINIB; IBUPROFEN; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PIROXICAM; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROTEIN KINASE C; RHO FACTOR; ROFECOXIB; SULINDAC; THALIDOMIDE; TRANSCRIPTION FACTOR NFAT; TRASTUZUMAB; UNINDEXED DRUG; WNT1 PROTEIN;

EID: 33744484033     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152006776930891     Document Type: Review
Times cited : (67)

References (329)
  • 31
    • 0036362181 scopus 로고    scopus 로고
    • Baselga, J. Oncologist, 2002, 7 Suppl 4, 2.
    • (2002) Oncologist , vol.7 , Issue.SUPPL. 4 , pp. 2
    • Baselga, J.1
  • 32
    • 0036361439 scopus 로고    scopus 로고
    • Ranson, M. Oncologist, 2002, 7 Suppl 4, 16.
    • (2002) Oncologist , vol.7 , Issue.SUPPL. 4 , pp. 16
    • Ranson, M.1
  • 81


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.